Article
Panelists talk about payment reform models, such as accountable care organizations and bundled payments, as a response to new treatments in oncology.
Lurbinectedin Plus Atezolizumab Maintenance Shows Improved Survival vs Atezolizumab in SCLC
Varied Access: The Pharmacogenetic Testing Coverage Divide
HHS Sets Pricing Target for Trump’s Most Favored Nation Drug Price Model
Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care
Is the US Headed for an Infectious Disease Pandemic?
Novel, Noninvasive Skin Cancer Detection Method Shows Promise